Showing results (481-490 of 649) with videos related to
Sort By:
Pageof 65
Journal of the Advanced Practitioner in Oncology|March 29, 2018
Clinical Management of Bowel Dysfunction After Low Anterior Resection for Rectal CancerAngela Bazzell, Lydia T Madsen, Joyce DainsJournal of the Advanced Practitioner in Oncology|December 29, 2017
Biomarkers/Molecular Targets, Immunotherapy, and Treatments for Non-Small Cell Lung CancerElizabeth S Waxman, Frank V FossellaJournal of the Advanced Practitioner in Oncology|December 20, 2018
Oncology Nurse Practitioner Web Education Resource(ONc-PoWER): An Evaluation of a Web-Enhanced Education Resource for Nurse Practitioners Who Are New to Cancer CareRosemary L Hoffmann, Sara Klein, Mary Connolly, et al.Journal of the Advanced Practitioner in Oncology|December 20, 2018
Combination Therapies in Advanced, Hormone Receptor-Positive Breast CancerEmily OlsonJournal of the Advanced Practitioner in Oncology|December 20, 2018
Management of Older Patients With Metastatic Renal Cell Carcinoma Receiving Sunitinib: A Hypothetical, Illustrative Case ScenarioSusan K Roethke, Joanne C Ryan, Sarah Yenser WoodJournal of the Advanced Practitioner in Oncology|December 20, 2018
Alectinib and Brigatinib: New Second-Generation ALK Inhibitors for the Treatment of Non-Small Cell Lung CancerTyler Beardslee, Justin LawsonJournal of the Advanced Practitioner in Oncology|August 1, 2022
Measuring Advanced Practice Provider Productivity at the National Comprehensive Cancer Network's Member InstitutionsDiana Krause, Karen Sharrah, Anne Gross, et al.Journal of the Advanced Practitioner in Oncology|August 1, 2022
Solid Pseudopapillary Neoplasm: A Single Institutional Case Series of a Rare Pancreatic TumorKristen Oase, Meguid Cheryl, Atsushi Oba, et al.Journal of the Advanced Practitioner in Oncology|August 1, 2022
Richter Transformation: Clinical Manifestations, Evaluation, and ManagementMelanie DouglasJournal of the Advanced Practitioner in Oncology|August 25, 2021
Transitioning From Thrombopoietin Agonists to the Novel SYK Inhibitor Fostamatinib: A Multicenter, Real-World Case SeriesDavid M Hughes, Charina Toste, Christopher Nelson, et al.Pageof 65